Hyponatraemia and Central Pontine Myelinolysis in Schizophrenia
This case study examines a 28-year-old male with diagnosed schizophrenia who was transferred from a psychiatric unit to an acute hospital following three episodes of tonic-clonic seizure and an altered conscious state. The paper presents the patient's demographic and clinical history, including a preceding episode of severe acute hyponatraemia (serum Na+ 104 mmol/L) and a subsequent diagnosis of psychogenic polydipsia. It critically evaluates health assessment findings, diagnostic investigations, and relevant clinical manifestations. The aetiology and pathophysiology of schizophrenia, hyponatraemia, and central pontine myelinolysis (CPM) are explored, with particular attention to the role of antipsychotic medications (risperidone and clozapine) in sodium dysregulation. Pharmacological and non-pharmacological interventions are discussed, along with psychosocial support recommendations for the patient and his family.
- Introduction: Overview of case study purpose and scope
- Patient Demographics and History: Patient background, diagnoses, and clinical timeline
- Health Assessment and Clinical Manifestations: Vital signs, assessment tools, and diagnostic findings
- Aetiology and Pathophysiology: Causes and mechanisms of hyponatraemia, CPM, and schizophrenia
- Intervention: Pharmacological and psychosocial treatment strategies
- Conclusion: Summary of diagnosis, treatment, and family support
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper integrates multiple co-occurring diagnoses — schizophrenia, severe acute hyponatraemia, psychogenic polydipsia, and central pontine myelinolysis — into a coherent clinical narrative, demonstrating an ability to reason across interconnected pathophysiological processes.
- It clearly distinguishes between aetiology (underlying cause) and pathophysiology (disease progression), then applies both frameworks to the patient's specific presentation, showing conceptual precision.
- The paper balances pharmacological and non-pharmacological interventions and extends its analysis to psychosocial support for caregivers, reflecting a holistic approach to patient-centered care.
Key academic technique demonstrated
The paper employs a case-study method grounded in clinical reasoning: evidence from the patient's history, vital signs, GCS score, and laboratory findings is systematically linked to diagnostic categories and treatment decisions. Each claim is supported by peer-reviewed citations, and competing explanations (e.g., risperidone vs. clozapine as causative agents) are acknowledged rather than dismissed, demonstrating scholarly nuance.
Structure breakdown
The paper follows a standard clinical case-study structure: introduction → patient history → health assessment and clinical manifestations (including diagnostic investigations) → aetiology and pathophysiology → interventions → conclusion. Each section builds on the previous one, moving from descriptive presentation of the patient's condition to explanatory and prescriptive analysis. References are formatted in APA style throughout.
Introduction
This case study concerns a 28-year-old male who was transferred from a psychiatric unit to an acute hospital following three episodes of tonic-clonic seizure with a subsequent altered conscious state. The purpose of the study is to provide details of the presenting problem, the health assessment, a critical evaluation of diagnostic investigations, clinical manifestations, aetiology and pathophysiology, interventions, and relevant evaluations.
Patient Demographics and History
The patient is a 28-year-old male with diagnosed schizophrenia. He lives with his parents and one older sister and has very good social support from his family. There is no primary family history of mental illness. He was a preterm baby (born at 34 weeks) and has since been diagnosed with psychogenic polydipsia — a diagnosis made following his most recent hospital admission.
The patient presented with seizures and was transferred from the psychiatric unit to the acute hospital after three episodes of tonic-clonic seizure with subsequent altered conscious state. However, four days prior to the seizures, he had been feeling unwell with nausea, vomiting, and lethargy. He had also appeared agitated, confused, disoriented, and unsteady on his feet, and had been holding his head as if in pain while intermittently staring into space. Doctors initially focused on his pre-existing condition of schizophrenia, but became concerned that a co-morbidity of delirium may have been the cause of the recent health deterioration.
This concern was based on the fact that seven days prior, the patient had presented with severe acute hyponatraemia (serum Na+ 104 mmol/L), which was corrected using hypertonic saline over approximately 28 hours until his serum Na+ reached 135 mmol/L. Three days later, he developed acute psychotic symptoms and was transferred to the psychiatric unit for ongoing management of his schizophrenia. He had been prescribed risperidone until his recent admission for hyponatraemia; he is now on clozapine.
Health Assessment and Clinical Manifestations
Upon assessment, it is important to consider the presenting problem in its entirety. In this case, given the patient's presentation with tonic-clonic seizure, severe acute hyponatraemia, and acute psychotic symptoms, a comprehensive physical examination was warranted. Assessment began with documentation of initial vital signs: temperature 37.6°C, blood pressure 115/60 mmHg, heart rate 91 beats per minute, and respiratory rate 22 breaths per minute. Oxygen saturation was 99% on room air, and the Glasgow Coma Scale (GCS) score was 10. Increased muscle tone throughout the limbs was also noted. Based on these findings, clinicians could formulate a plan to further assess and treat the patient.
Several approaches and techniques are relevant when undertaking a physical assessment for someone presenting with tonic-clonic seizure, severe acute hyponatraemia, and acute psychotic symptoms. One approach is to use the GCS (Singh et al., 2019), a common tool used to assess level of consciousness. For a patient presenting with tonic-clonic seizure, the GCS may be used to determine seizure severity and to identify associated neurological deficits (Pruitt et al., 2019). In addition, the GCS can be used to assess for acute psychotic symptoms such as delusions or hallucinations (Khalid et al., 2021). A detailed physical examination can help identify physical abnormalities that may be causing or contributing to the presentation — in this case, heightened muscle tone in the limbs was identified through this process. Finally, laboratory tests can help rule out other potential causes and provide information about the severity of the patient's condition (Bazmi et al., 2020).
Several objective and subjective clinical manifestations could be expected in someone presenting with this combination of conditions. Seizure activity would likely be noted on EEG, and the patient may exhibit impaired cognition or a brief loss of consciousness. Subjective symptoms such as auras or fear may also be reported (Braatz et al., 2021). A patient with severe acute hyponatraemia may present with delirium, seizures, or coma, while those with acute psychotic symptoms may exhibit disorganized thinking, hallucinations, or delusions (Adrogue et al., 2022). All of these manifestations must be taken into account to properly diagnose and treat the patient.
The diagnostic investigations were significant for the following findings: tonic-clonic seizure, severe acute hyponatraemia, acute psychotic symptoms, and a GCS score of 10. These findings are consistent with a diagnosis of psychogenic polydipsia. The patient's history of psychiatric problems and use of antipsychotic medications likely contributed to the development of this condition. It remains unclear whether risperidone or clozapine are factors in the onset of symptoms, as either medication could serve as an agent of destabilization (Kumar & Kukreti, 2020). Both are atypical antipsychotic medications commonly used to treat schizophrenia, but adverse effects can be observed in some patients (Kumar & Kukreti, 2020).
Further clinical assessments and diagnostic investigations that should be conducted include: a brain MRI to assess the level of normal brain activity; an EEG to determine whether there is any evidence of generalized slowing; a lumbar puncture to assess for elevated intracranial pressure; and a CT scan of the head to identify any mass lesions or hydrocephalus (Helms et al., 2020). In the meantime, the patient should be treated with intravenous fluids, antiepileptic medication, and a course of steroids, with ongoing monitoring pending further investigation.
Conclusion
The patient is a 28-year-old male with diagnosed schizophrenia who lives with his parents and older sister and has very good social support from his family. He presented with seizures and an altered conscious state following a preceding episode of severe acute hyponatraemia, during which medication was adjusted once sodium levels had balanced out. It is now believed that he is experiencing severe acute hyponatraemia with possible central pontine myelinolysis. Assessment began with documentation of his initial vital signs. Diagnostic investigations indicated tonic-clonic seizure, severe acute hyponatraemia, and acute psychotic symptoms; with a GCS score of 10, these findings were consistent with a diagnosis of psychogenic polydipsia. Clozapine is a relevant pharmacological intervention for psychogenic polydipsia (Ahmadi & Goldman, 2020) and should be continued under close monitoring. All other interventions should be directed at correcting the underlying causes of psychogenic polydipsia, hyponatraemia, and CPM, and managing the associated symptoms. Counseling and psychosocial support should be provided to the patient's parents.
References
Abram, S. V., Hua, J. P., & Ford, J. M. (2022). Consider the pons: bridging the gap on sensory prediction abnormalities in schizophrenia. Trends in Neurosciences.
Adrogué, H. J., Tucker, B. M., & Madias, N. E. (2022). Diagnosis and management of hyponatremia: A review. JAMA, 328(3), 280–291.
Ahmadi, L., & Goldman, M. B. (2020). Primary polydipsia: Update. Best Practice & Research Clinical Endocrinology & Metabolism, 34(5), 101469.
Bazmi, E., Behnoush, B., Nazari, S. H., Khodakarim, S., Behnoush, A. H., & Soori, H. (2020). Seizure prediction model in acute tramadol poisoning: A derivation and validation study. Archives of Academic Emergency Medicine, 8(1).
Braatz, V., Martins Custodio, H., Leu, C., Agrò, L., Wang, B., Calafato, S., … & Sisodiya, S. M. (2021). Postictal psychosis in epilepsy: A clinicogenetic study. Annals of Neurology, 90(3), 464–476.
Fernandez Martinez, A., Barajas Galindo, D., & Ruiz Sanchez, J. (2021). Management of hyponatraemia and hypernatraemia during the Covid-19 pandemic: A consensus statement of the Spanish Society for Endocrinology (Acqua Neuroendocrinology Group). Reviews in Endocrine and Metabolic Disorders, 22(2), 317–324.
Helms, J., Kremer, S., Merdji, H., Schenck, M., Severac, F., Clere-Jehl, R., … & Meziani, F. (2020). Delirium and encephalopathy in severe COVID-19: A cohort analysis of ICU patients. Critical Care, 24(1), 1–11.
Khalid, M., Malik, M., Anandappa, S., Sivappriyan, S., & Kumar, J. (2021, October). Hashimoto's encephalopathy: Organic psychosis vs catatonic schizophrenia. In Endocrine Abstracts (Vol. 77). Bioscientifica.
Kumar, N., & Kukreti, P. (2020). Delirium: Assessment and management — A review. Journal of Advanced Research in Psychology & Psychotherapy, 3(3&4), 21–27.
Peritogiannis, V., & Rizos, D. V. (2021). Catatonia associated with hyponatremia: Case report and brief review of the literature. Clinical Practice and Epidemiology in Mental Health: CP & EMH, 17, 26.
Piffer, A., Bianchetti, M. G., Leoni-Foglia, C., Simonetti, G. D., Milani, G. P., & Lava, S. A. (2022). Vaptans for edematous and hyponatremic disorders in childhood: A systematic literature review. British Journal of Clinical Pharmacology.
Pruitt, P., Naidech, A., Van Ornam, J., & Borczuk, P. (2019). Seizure frequency in patients with isolated subdural hematoma and preserved consciousness. Brain Injury, 33(8), 1059–1063.
Riebschleger, J., Costello, S., Cavanaugh, D. L., & Grové, C. (2019). Mental health literacy of youth that have a family member with a mental illness: Outcomes from a new program and scale. Frontiers in Psychiatry, 10, 2.
Siddiqui, J. A., Qureshi, S. F., & Alghamdi, A. K. (2020). Psychogenic polydipsia leading to hyponatremia induced seizure in schizophrenia. Psychiatry and Behavioral Sciences, 10(3), 158–160.
Sindahl, P., Overgaard-Steensen, C., Wallach-Kildemoes, H., De Bruin, M. L., Leufkens, H. G., Kemp, K., & Gardarsdottir, H. (2020). Are further interventions needed to prevent and manage hospital-acquired hyponatraemia? A nationwide cross-sectional survey of IV fluid prescribing practices. Journal of Clinical Medicine, 9(9), 2790.
Singh, G., Paul, B., Chaudhary, A., & Singh, G. (2019). Impact of epileptic seizures in the neurological intensive care unit (NICU) on Glasgow Coma Scale (GCS). Epilepsy & Behavior, 101.
Yang, Q., Guo, X., & Liu, D. (2018). Hypokalemia caused by quetiapine and risperidone treatment in schizophrenia: A case report. Shanghai Archives of Psychiatry, 30(3), 204.
Young, L., Murata, L., McPherson, C., Jacob, J. D., & Vandyk, A. D. (2019). Exploring the experiences of parent caregivers of adult children with schizophrenia: A systematic review. Archives of Psychiatric Nursing, 33(1), 93–103.
Always verify citation format against your institution’s current style guide requirements.